TNF and Sepsis: In a study by Mahmoodpoor et al., the effect of IMODTM on controlling signs and symptoms and treatment of patients with sepsis was evaluated and it was reported that TNF-α levels, as a chief inflammatory mediator involved in sepsis, significantly decreased after treatment with IMODTM compared to the control group [11].